Company
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
MAY 6, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval for labeling change to leuprolide acetate; regulatory action does not report clinical trial outcomes or efficacy data.
MAY 6, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval for labeling update to leuprolide acetate; regulatory action does not report clinical trial outcomes or efficacy data.